Molecular Tumor Board Solutions Market, By Component (Software and Services), By Solution, By Cancer Type, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV5965
|
Published Date
September 2026
|
Pages
354
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Molecular Tumor Board Solutions Market size was valued at USD 1,801.6 Million in 2025, expanding to a CAGR of 14.2% from 2026 to 2033.
The molecular tumor board (MTB) solutions market includes software platforms, clinical decision-support systems, genomic interpretation tools, data-management platforms, and related Cancer Type that enable multidisciplinary oncology teams to evaluate and manage complex cancer cases. These solutions offer thorough case assessment and individualized treatment planning by combining genomic sequencing data, pathology findings, clinical history, biomarkers, medication information, and other patient-specific data.
Molecular Tumor Board Solutions Market- Market Dynamics
Increasing adoption of precision oncology & genomic testing and need for clinical decision support are expected to propel market demand
The increasing adoption of precision oncology and comprehensive genomic profiling is a key factor driving the growth of the molecular tumor board solutions market. Gene mutations, copy-number variations, gene fusions, biomarkers, and other molecular abnormalities are among the increasingly complex datasets produced by the widespread use of next-generation sequencing (NGS) and other cutting-edge molecular diagnostic technologies. Multidisciplinary experts, including as oncologists, pathologists, molecular biologists, geneticists, bioinformaticians, and others, are frequently needed to interpret these results. By integrating and organizing molecular and clinical data and connecting genomic findings with clinical recommendations, scientific literature, targeted medicines, and pertinent clinical trials, MTB solutions facilitate this process. This makes it possible for interdisciplinary teams to have better organized, evidence-based therapy conversations. 20.8% of patients got treatments suggested by molecular tumour boards, according to a 2025 healthcare assessment of 34 research including 12,176 patients, indicating the expanding role of MTB-based techniques in cancer treatment.
Demand for digital and AI-enabled molecular tumour board solutions that can simplify case preparation, lessen administrative workload, and improve clinical interpretation is being driven by the growing volume, diversity, and complexity of oncology data. Prior to multidisciplinary conversations, traditional MTB procedures frequently need a substantial amount of time and effort to gather and examine patient records, genetic sequencing reports, pathology findings, scientific literature, therapeutic recommendations, and pertinent clinical trial data. By consolidating clinical and molecular data into a single setting, digital MTB platforms help to overcome these obstacles by facilitating quicker access to pertinent patient data and more effective case review. Data aggregation, literature and evidence retrieval, biomarker interpretation, and other tasks can be further automated by integrating AI and advanced analytics.
Molecular Tumor Board Solutions Market- Segmentation Analysis:
The Global Molecular Tumor Board Solutions Market is segmented on the basis of Component, Solution, Cancer Type, End-Use, and Region.
The market is divided into six categories based on Solution: clinical decision support, genomic data interpretation, data analytics, reporting & visualization, patient case management, and others. By solution, clinical decision support segment is anticipated to have a considerable revenue share in the market. Clinical decision-support platforms provide the digital infrastructure needed to consolidate patient data, organize and interpret molecular findings, streamline case preparation, facilitate multidisciplinary discussions, document treatment recommendations, and support ongoing patient follow-up. Roche\'s navify Clinical Hub for Tumor Boards, for example, provides meeting coordination, patient-list management.
Molecular Tumor Board Solutions Market- Geographical Insights
North America\'s robust precision oncology ecosystem, vast genomic testing infrastructure, extensive network of specialized cancer centres, and widespread adoption of digital clinical decision-support technologies all contribute to the region\'s dominant position in the molecular tumour board solutions market. Healthcare facilities, technological companies, and oncology-focused groups engaged in genetic interpretation, clinical informatics, and molecular tumour board services are particularly prevalent in the United States. Developed healthcare systems, cutting-edge cancer research skills, university medical centres, and the growing use of precision medicine are what propel the European market. The region\'s nations are focusing more on standardizing molecular tumour board procedures, enhancing the incorporation of genomic testing into regular cancer treatment, and bolstering cooperation between clinical, diagnostic, and research teams.
India Molecular Tumor Board Solutions Market- Key Insights
India\'s rising cancer incidence, developing precision-oncology capabilities, improving diagnostic infrastructure, and increased access to genomic testing all contribute to the country\'s potential as a market for molecular tumor board solutions. With businesses like MedGenome and other specialized providers supporting the adoption of genomic-based cancer assessment and individualized treatment options, the nation is also fortifying its ecosystem of molecular diagnostics and genomic testing. However, a number of obstacles, such as unequal access to sophisticated oncology and the expensive cost of complete genetic sequencing, limit market expansion. The use of MTB solutions is anticipated to grow throughout India\'s main cancer centers and specialist oncology networks as genomic testing becomes more widely available and digital healthcare infrastructure advances.
Molecular Tumor Board Solutions Market- Competitive Landscape:
The molecular tumor board solutions market is highly competitive and continuously evolving, with participation from healthcare technology companies, diagnostic & genomic-testing providers, oncology software developers, academic medical centers, pharmaceutical companies, and specialized clinical decision-support firms. Market participants are differentiating themselves through advanced genomic interpretation, clinical decision support, workflow automation, electronic health record (EHR) integration, AI-enabled analytics, and seamless data management. A key competitive trend is the shift from basic digital tools for tumor board coordination toward integrated precision-oncology platforms. Patient records, genomic profiles, pathology data, therapy recommendations, scientific literature, and clinical trial data are all being integrated into a single workflow by these platforms.
Recent Developments:
- In June 2025, Roche Diagnostics Japan enhanced its navify Tumor Board software to accommodate gene-panel testing for hematological malignancies, broadening the platform’s molecular tumor-board capabilities beyond solid-tumor applications.
- In May 2025, Tempus announced that 10 abstracts had been selected for presentation at the 2025 ASCO Annual Meeting, showcasing the company’s advancements in AI-driven precision oncology and molecularly informed cancer care.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET KEY PLAYERS
- Roche
- Tempus AI, Inc.
- Caris Life Sciences
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Syapse, Inc.
- GenomOncology, LLC
- Molecular Health GmbH
- SOPHiA GENETICS
- QIAGEN N.V.
- Guardant Health, Inc.
- Myriad Genetics, Inc.
- NantHealth, Inc.
- MedGenome
- CureMatch
- Variantyx, Inc.
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Software
- Services
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY SOLUTION- MARKET ANALYSIS, 2020-2033
- Clinical Decision Support
- Genomic Data Interpretation
- Data Analytics
- Reporting & Visualization
- Patient Case Management
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Hematological Malignancies
- Prostate Cancer
- Melanoma
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
- Hospitals
- Specialized Cancer Centers
- Research Institutes
- Diagnostic Laboratories
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENTS
1. Molecular Tumor Board Solutions Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Molecular Tumor Board Solutions Market Snippet by Component
2.1.2. Molecular Tumor Board Solutions Market Snippet by Solution
2.1.3. Molecular Tumor Board Solutions Market Snippet by Cancer Type
2.1.4. Molecular Tumor Board Solutions Market Snippet by End-Use
2.1.5. Molecular Tumor Board Solutions Market Snippet by Country
2.1.6. Molecular Tumor Board Solutions Market Snippet by Region
2.2. Competitive Insights
3. Molecular Tumor Board Solutions Key Market Trends
3.1. Molecular Tumor Board Solutions Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Molecular Tumor Board Solutions Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Molecular Tumor Board Solutions Market Opportunities
3.4. Molecular Tumor Board Solutions Market Future Trends
4. Molecular Tumor Board Solutions Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Molecular Tumor Board Solutions Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Molecular Tumor Board Solutions Market Landscape
6.1. Molecular Tumor Board Solutions Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Molecular Tumor Board Solutions Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
7.1.2. Software
7.1.3. Services
8. Molecular Tumor Board Solutions Market – By Solution
8.1. Overview
8.1.1. Segment Share Analysis, By Solution, 2025 & 2033 (%)
8.1.2. Clinical Decision Support
8.1.3. Genomic Data Interpretation
8.1.4. Data Analytics
8.1.5. Reporting & Visualization
8.1.6. Patient Case Management
8.1.7. Others
9. Molecular Tumor Board Solutions Market – By Cancer Type
9.1. Overview
9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
9.1.2. Lung Cancer
9.1.3. Breast Cancer
9.1.4. Colorectal Cancer
9.1.5. Hematological Malignancies
9.1.6. Prostate Cancer
9.1.7. Melanoma
9.1.8. Others
10. Molecular Tumor Board Solutions Market – By End-Use
10.1. Overview
10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Specialized Cancer Centers
10.1.4. Research Institutes
10.1.5. Diagnostic Laboratories
10.1.6. Others
11. Molecular Tumor Board Solutions Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Molecular Tumor Board Solutions Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Molecular Tumor Board Solutions Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Molecular Tumor Board Solutions Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Molecular Tumor Board Solutions Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Molecular Tumor Board Solutions Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Solution, 2020 - 2033 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Molecular Tumor Board Solutions Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Roche
12.2.2. Tempus AI, Inc.
12.2.3. Caris Life Sciences
12.2.4. Illumina, Inc.
12.2.5. Thermo Fisher Scientific Inc.
12.2.6. Syapse, Inc.
12.2.7. GenomOncology, LLC
12.2.8. Molecular Health GmbH
12.2.9. SOPHiA GENETICS
12.2.10. QIAGEN N.V.
12.2.11. Guardant Health, Inc.
12.2.12. Myriad Genetics, Inc.
12.2.13. NantHealth, Inc.
12.2.14. MedGenome
12.2.15. CureMatch
12.2.16. Variantyx, Inc.
12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET KEY PLAYERS
- Roche
- Tempus AI, Inc.
- Caris Life Sciences
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Syapse, Inc.
- GenomOncology, LLC
- Molecular Health GmbH
- SOPHiA GENETICS
- QIAGEN N.V.
- Guardant Health, Inc.
- Myriad Genetics, Inc.
- NantHealth, Inc.
- MedGenome
- CureMatch
- Variantyx, Inc.
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033
- Software
- Services
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY SOLUTION- MARKET ANALYSIS, 2020-2033
- Clinical Decision Support
- Genomic Data Interpretation
- Data Analytics
- Reporting & Visualization
- Patient Case Management
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Hematological Malignancies
- Prostate Cancer
- Melanoma
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033
- Hospitals
- Specialized Cancer Centers
- Research Institutes
- Diagnostic Laboratories
- Others
GLOBAL MOLECULAR TUMOR BOARD SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
